Emcure Pharmaceuticals Q4 Results

  • BSE: 544210
  • NSE: EMCURE
  • ISIN: INE168P01015
  • Sector: -
BSE
1,317.553.95 (0.30%)
Volume3.73 K
Updated: Mon 25 Nov, 2024 | 15:29:04
NSE
1,312.05-2.10 (-0.16%)
Volume1.01 L
Updated: Mon 25 Nov, 2024 | 15:31:30
Today: 1,292.15
1,333.95
52-Wk: 1,226.50
1,577.50

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Emcure Pharmaceuticals Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24-QoQ CompMar 23YoY Comp
    Total Revenue 6,658.25--%5,985.81-%
    Selling/ General/ Admin Expenses Total 1,913.31--%1,605.41-%
    Depreciation/ Amortization 312.41--%260.12-%
    Other Operating Expenses Total 919.76--%829.77-%
    Total Operating Expense 5,750.87--%5,070.56-%
    Operating Income 907.38--%915.25-%
    Net Income Before Taxes 727.23--%747.21-%
    Net Income 498.18--%532.02-%
    Diluted Normalized EPS 26.45--%28.39-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts